Latest News about ACAD
Recent news which mentions ACAD
Why Acadia Pharmaceuticals Stock Climbed More Than 10% Wednesday
December 22, 2021
Tickers
ACAD
From Motley Fool
55 Biggest Movers From Yesterday
December 22, 2021
From Benzinga
Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
December 21, 2021
Tickers
ACAD
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 21, 2021
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
December 21, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 20, 2021
From Benzinga
Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?
December 08, 2021
From Motley Fool
What 7 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
December 07, 2021
Tickers
ACAD
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 07, 2021
From Benzinga
10 Biggest Price Target Changes For Tuesday
December 07, 2021
From Benzinga
From InvestorPlace
22 Stocks Moving in Tuesday's Pre-Market Session
December 07, 2021
From Benzinga
Acadia Pharma Jumps After Rett Syndrome Candidate Aces Phase 3 Study
December 07, 2021
Tickers
ACAD
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 06, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 09, 2021
From Benzinga
Acadia Pharmaceuticals Inc (ACAD) Q3 2021 Earnings Call Transcript
November 09, 2021
Tickers
ACAD
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
From Benzinga
3 Biotech Stocks to Watch Now
October 12, 2021
From Benzinga
Can These Former Biotech Growth Stocks Regain Their Form?
September 29, 2021
From Motley Fool
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
Looking into ACADIA Pharmaceuticals's Return on Capital Employed
August 20, 2021
Tickers
ACAD
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.